Search Within


Present Drug Therapy of Demyelinating Disorders

Journal: Current Drug Therapy
Volume: 13, Issue: 1
Page: 25-42
Authors: Yuval Karmon and Natan Gadoth*

Role of AQP4 Antibody Serostatus and its Prediction of Visual Outcome in Neuromyelitis Optica: A Systematic Review and Meta-Analysis

Journal: Protein & Peptide Letters
Volume: 24, Issue: 3
Page: 245-252
Authors: Nan Lin, Qing Liu, Xiaoyu Wang, Jianmei Ma and Yuyuan Li

HCV-Related Central and Peripheral Nervous System Demyelinating Disorders

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 13, Issue: 5
Page: 299-304
Authors: Sara Mariotto, Sergio Ferrari and Salvatore Monaco

Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach

Journal: Current Pharmaceutical Design
Volume: 14, Issue: 13
Page: 1261-1269
Authors: Giovanni Sanna, Maria Laura Bertolaccini and Munther A. Khamashta

Treatment of Central Nervous System Involvement Associated with Primary Sjogrens Syndrome

Journal: Current Pharmaceutical Design
Volume: 14, Issue: 13
Page: 1270-1273
Authors: Salih Ozgocmen and Ali Gur

Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices

Journal: Current Neuropharmacology
Volume: 9, Issue: 3
Page: 417-428
Authors: Amer Awad and Olaf Stuve

Antiphospholipid Syndrome as a Neurological Disease

Journal: Current Rheumatology Reviews
Volume: 6, Issue: 1
Page: 12-17
Authors: Carlos Ewerton Maia Rodrigues, Jozelio Freire Carvalho and Yehuda Shoenfeld